Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Diabetes. Nov 15, 2026; 17(11): 120214
Published online Nov 15, 2026. doi: 10.4239/wjd.120214
Published online Nov 15, 2026. doi: 10.4239/wjd.120214
Clinical significance of detection of serum C-reactive protein-fasting C-peptide product, remnant cholesterol and 25-hydroxyvitamin D in type 2 diabetes mellitus
Osama M Ahmed, Physiology Division, Department of Zoology, Faculty of Science, Beni-Suef University, Beni-Suef 62521, Egypt
Author contributions: Ahmed OM written and revised the editorial.
Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.
Corresponding author: Osama M Ahmed, PhD, Physiology Division, Department of Zoology, Faculty of Science, Beni-Suef University, P.O.Box 62521, Salah Salem Street, Beni-Suef 62521, Egypt. osama.ahmed@science.bsu.edu.eg
Received: February 27, 2026
Revised: March 27, 2026
Accepted: April 24, 2026
Published online: November 15, 2026
Processing time: 258 Days and 9.2 Hours
Revised: March 27, 2026
Accepted: April 24, 2026
Published online: November 15, 2026
Processing time: 258 Days and 9.2 Hours
Core Tip
Core Tip: The elevated levels of C-reactive protein and fasting C-peptide product and remnant cholesterol and the low levels of 25-hydroxyvitamin D in combination are strong promising and emerging predictors for type 2 diabetes mellitus and for cardiovascular disease and other complications in type 2 diabetes mellitus. This integrative approach allows for better identification of high-risk patients, more accurate prognosis forecasting, and tailored therapeutic strategies.